Clinical Trials in Austin

Showing 2521-2540 of 15,205 trials

Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF)

NCT00948831

This study is being conducted to determine the percentage of patients with solid spinal fusions after being treated with Osteocel Plus in an ALIF procedure. Due to the unique processing conditions, Osteocel Plus retains a high concentration of stem cells in conjunction with the allograft bone matrix, so it is hypothesized that the fusion rate with Osteocel Plus will be comparable to published data for autograft. The Osteocel product family has already been used in approximately 15,000 cases worldwide.

Degenerative Disc Disease, Lumbar

NuVasive51 participantsStarted Apr 2009

San Francisco, California, United States • Indianapolis, Indiana, United States • Kokomo, Indiana, United States +4 more locations

RECRUITINGPhase 3< 1 mile

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

NCT07300839

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

COVID-19SARS-COV-2 Infection

BioNTech SE25,500 participantsStarted Dec 2025

Anniston, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +205 more locations

Osteocel® Plus in Anterior Lumbar Interbody Fusion (ALIF)

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Find Trials by Condition in Austin

SpineTRACK Registry - Spinal Outcomes Registry

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Stroke Thrombectomy and Aneurysm Registry

A Study of YL242 in Subjects With Advanced Solid Tumors

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Study of Pregnancy And Neonatal Health (SPAN)

Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

Clinical and Molecular Studies in Families With Inherited Eye Disease